Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 3/2017

06.12.2016 | Basic Science

Effects of 4-methylumbelliferone and high molecular weight hyaluronic acid on the inflammation of corneal stromal cells induced by LPS

verfasst von: Fang Li, Peng Hao, Guangjie Liu, Weiyi Wang, Ruifang Han, Zhixin Jiang, Xuan Li

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the effects of hyaluronic acid (HA) on the inflammation of corneal fibroblasts induced by lipopolysaccharide (LPS).

Methods

Primary rabbit corneal keratocytes were isolated with collagenase. The keratocytes were cultured in a serum-containing medium to induce corneal fibroblasts, which represented the wound repair phenotype of corneal keratocytes. Corneal fibroblasts were treated with LPS with or without 4-methylumbelliferone (4-MU) / high molecular weight hyaluronic acid (HMWHA). The gene expression was evaluated via real-time PCR, immunofluorescence, and western blot. The release of inflammatory cytokines and HA was determined by ELISA.

Results

Three types of hyaluronan synthase (HAS) were detected in corneal fibroblasts. LPS stimulation caused the up-regulation of HAS1 and HAS2 expression in corneal fibroblasts. LPS-induced HAS2 expression was significantly inhibited by 4-MU, and accompanied by decreased HA release by the corneal fibroblasts. In the corneal fibroblasts, 4-MU reduced the LPS-stimulated up-regulation of inflammatory cytokines including IL-1, IL-6, IL-8, TNF-α, and also attenuated the LPS-induced up-regulation of inflammatory related receptors including TLR2, TLR4, CD44, and CXCR1. HMWHA treatment resulted in a significant decline in the expression of IL-6, IL-8, TLR4, and CXCR1 responded to LPS stimulation. Consistent with mRNA expression of level, the up-regulation of the release of IL-6 and IL-8 induced by LPS in corneal fibroblasts was significantly attenuated by 4-MU and HMWHA. The LPS-induced expression of IL-8 and its receptor CXCR1 at both the mRNA and protein level were significantly attenuated by 4-MU and HMWHA.

Conclusion

The inhibitor of HA synthesis 4-MU, and HMWHA successfully reduced LPS-induced inflammation in corneal fibroblasts. The mechanism might be via the inhibition of LPS-induced TLR4 up-regulation.
Literatur
1.
Zurück zum Zitat Schaefer FDR, Bruttin O, Zografos LO, Guex-Crosier Y (2001) Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 10(5):842–847CrossRef Schaefer FDR, Bruttin O, Zografos LO, Guex-Crosier Y (2001) Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 10(5):842–847CrossRef
2.
Zurück zum Zitat Guo N et al (2007) A rapid transient increase in hyaluronan synthase-2 mRNA initiates secretion of hyaluronan by corneal keratocytes in response to transforming growth factor beta. J Biol Chem 282(17):12475–12483CrossRefPubMedPubMedCentral Guo N et al (2007) A rapid transient increase in hyaluronan synthase-2 mRNA initiates secretion of hyaluronan by corneal keratocytes in response to transforming growth factor beta. J Biol Chem 282(17):12475–12483CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Kumagai N et al (2005) Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci 46(1):114–120CrossRefPubMed Kumagai N et al (2005) Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci 46(1):114–120CrossRefPubMed
4.
Zurück zum Zitat Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T (2006) Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res 25(2):165–187CrossRefPubMed Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T (2006) Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res 25(2):165–187CrossRefPubMed
5.
Zurück zum Zitat Lu Y et al (2006) Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Invest Ophthalmol Vis Sci 47(9):3796–3800CrossRefPubMed Lu Y et al (2006) Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Invest Ophthalmol Vis Sci 47(9):3796–3800CrossRefPubMed
7.
Zurück zum Zitat Mitsui Y et al (2008) Hyaluronic acid inhibits mRNA expression of proinflammatory cytokines and cyclooxygenase-2/prostaglandin E(2) production via CD44 in interleukin-1-stimulated subacromial synovial fibroblasts from patients with rotator cuff disease. J Orthop Res 26(7):1032–1037CrossRefPubMed Mitsui Y et al (2008) Hyaluronic acid inhibits mRNA expression of proinflammatory cytokines and cyclooxygenase-2/prostaglandin E(2) production via CD44 in interleukin-1-stimulated subacromial synovial fibroblasts from patients with rotator cuff disease. J Orthop Res 26(7):1032–1037CrossRefPubMed
8.
Zurück zum Zitat Campo GM et al (2011) Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta 1812(9):1170–1181CrossRefPubMed Campo GM et al (2011) Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta 1812(9):1170–1181CrossRefPubMed
9.
Zurück zum Zitat Kogan G, Soltés L, Stern R, Gemeiner P (2007) Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 29(1):17–25CrossRefPubMed Kogan G, Soltés L, Stern R, Gemeiner P (2007) Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 29(1):17–25CrossRefPubMed
10.
Zurück zum Zitat Vigetti D et al (2014) Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta 1840(8):2452–2459CrossRefPubMed Vigetti D et al (2014) Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta 1840(8):2452–2459CrossRefPubMed
11.
Zurück zum Zitat Schulz A, Vestweber AM, Dressler D (2009) Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model. Aktuelle Urol 40(2):109–112CrossRefPubMed Schulz A, Vestweber AM, Dressler D (2009) Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model. Aktuelle Urol 40(2):109–112CrossRefPubMed
12.
Zurück zum Zitat Hirabara S, Kojima T, Takahashi N, Hanabayashi M, Ishiguro N (2013) Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts. Biochem Biophys Res Commun 430(2):519–522CrossRefPubMed Hirabara S, Kojima T, Takahashi N, Hanabayashi M, Ishiguro N (2013) Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts. Biochem Biophys Res Commun 430(2):519–522CrossRefPubMed
13.
Zurück zum Zitat Pauloin T, Dutot M, Joly F, Warnet JM, Rat P (2009) High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 15:577–583PubMedPubMedCentral Pauloin T, Dutot M, Joly F, Warnet JM, Rat P (2009) High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 15:577–583PubMedPubMedCentral
14.
Zurück zum Zitat Pauloin T et al (2009) Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects. Cornea 28(9):1032–1041CrossRefPubMed Pauloin T et al (2009) Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects. Cornea 28(9):1032–1041CrossRefPubMed
15.
Zurück zum Zitat Muto J, Yamasaki K, Taylor KR, Gallo RL (2009) Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 47(2–3):449–456CrossRefPubMedPubMedCentral Muto J, Yamasaki K, Taylor KR, Gallo RL (2009) Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 47(2–3):449–456CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Campo GM et al (2010) Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie 92(2):204–215CrossRefPubMed Campo GM et al (2010) Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie 92(2):204–215CrossRefPubMed
17.
Zurück zum Zitat Baeva LF, Lyle DB, Rios M, Langone JJ, Lightfoote MM (2014) Different molecular weight hyaluronic acid effects on human macrophage interleukin 1beta production. J Biomed Mater Res A 102(2):305–314CrossRefPubMed Baeva LF, Lyle DB, Rios M, Langone JJ, Lightfoote MM (2014) Different molecular weight hyaluronic acid effects on human macrophage interleukin 1beta production. J Biomed Mater Res A 102(2):305–314CrossRefPubMed
18.
Zurück zum Zitat Lokeshwar VB et al (2010) Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res 70(7):2613–2623CrossRefPubMedPubMedCentral Lokeshwar VB et al (2010) Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res 70(7):2613–2623CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Kakizaki I et al (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279(32):33281–33289CrossRefPubMed Kakizaki I et al (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279(32):33281–33289CrossRefPubMed
20.
Zurück zum Zitat Guo N et al (2010) Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta. J Biol Chem 285(42):32012–32019CrossRefPubMedPubMedCentral Guo N et al (2010) Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta. J Biol Chem 285(42):32012–32019CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat El-Asrar AM et al (2011) CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology 216(9):1004–1009CrossRefPubMed El-Asrar AM et al (2011) CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology 216(9):1004–1009CrossRefPubMed
22.
Zurück zum Zitat Lapp T et al (2015) Identification of therapeutic targets of inflammatory monocyte recruitment to modulate the allogeneic injury to donor cornea. Invest Ophthalmol Vis Sci 56(12):7250–7259CrossRefPubMed Lapp T et al (2015) Identification of therapeutic targets of inflammatory monocyte recruitment to modulate the allogeneic injury to donor cornea. Invest Ophthalmol Vis Sci 56(12):7250–7259CrossRefPubMed
23.
Zurück zum Zitat Takeuchi O et al (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11(4):443–451CrossRefPubMed Takeuchi O et al (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11(4):443–451CrossRefPubMed
24.
Zurück zum Zitat Jiang D et al (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11(11):1173–1179CrossRefPubMed Jiang D et al (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11(11):1173–1179CrossRefPubMed
25.
Zurück zum Zitat Kim MY, Muto J, Gallo RL (2013) Hyaluronic acid oligosaccharides suppress TLR3-dependent cytokine expression in a TLR4-dependent manner. PLoS One 8(8):e72421CrossRefPubMedPubMedCentral Kim MY, Muto J, Gallo RL (2013) Hyaluronic acid oligosaccharides suppress TLR3-dependent cytokine expression in a TLR4-dependent manner. PLoS One 8(8):e72421CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat McKallip RJ, Hagele HF, Uchakina ON (2013) Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses SEB-induced lung inflammation. Toxins 5(10):1814–1826CrossRefPubMedPubMedCentral McKallip RJ, Hagele HF, Uchakina ON (2013) Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses SEB-induced lung inflammation. Toxins 5(10):1814–1826CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat McKallip RJ, Ban H, Uchakina ON (2015) Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation. Inflammation 38(3):1250–1259CrossRefPubMed McKallip RJ, Ban H, Uchakina ON (2015) Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation. Inflammation 38(3):1250–1259CrossRefPubMed
28.
Zurück zum Zitat Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85(8):699–715CrossRefPubMed Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85(8):699–715CrossRefPubMed
29.
Zurück zum Zitat Campo GM (2009) Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch Biochem Biophys 491:7–15CrossRefPubMed Campo GM (2009) Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch Biochem Biophys 491:7–15CrossRefPubMed
30.
Zurück zum Zitat Liang J et al (2007) CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 178(4):2469–2475CrossRefPubMed Liang J et al (2007) CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 178(4):2469–2475CrossRefPubMed
31.
Zurück zum Zitat Kawana H et al (2008) CD44 suppresses TLR-mediated inflammation. J Immunol 180(6):4235–4245CrossRefPubMed Kawana H et al (2008) CD44 suppresses TLR-mediated inflammation. J Immunol 180(6):4235–4245CrossRefPubMed
32.
Zurück zum Zitat Boone DL et al (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5(10):1052–1060CrossRefPubMed Boone DL et al (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5(10):1052–1060CrossRefPubMed
33.
Zurück zum Zitat Zhang G, Ghosh S (2002) Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 277(9):7059–7065CrossRefPubMed Zhang G, Ghosh S (2002) Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 277(9):7059–7065CrossRefPubMed
35.
Zurück zum Zitat Mongkhon JM et al (2014) Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes. Inflamm Res 63(8):691–701CrossRefPubMed Mongkhon JM et al (2014) Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes. Inflamm Res 63(8):691–701CrossRefPubMed
Metadaten
Titel
Effects of 4-methylumbelliferone and high molecular weight hyaluronic acid on the inflammation of corneal stromal cells induced by LPS
verfasst von
Fang Li
Peng Hao
Guangjie Liu
Weiyi Wang
Ruifang Han
Zhixin Jiang
Xuan Li
Publikationsdatum
06.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3561-1

Weitere Artikel der Ausgabe 3/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 3/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.